Cargando…

Epidermal growth factor receptor tyrosine kinase inhibitors combined with thoracic radiotherapy or chemoradiotherapy for advanced or metastatic non-small cell lung cancer: A systematic review and meta-analysis of single-arm trials

BACKGROUND: Preclinical in vitro experiments demonstrated that epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) might have synergistic effect in combination with radiotherapy on Non-small cell lung cancer (NSCLC), but the clinical trials showed inconsistence results in NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ruifeng, Wei, Shihong, Zhang, Qiuning, Zhang, Xueliang, Luo, Hongtao, Tian, Jinhui, Li, Yi, Ge, Long, Wang, Xiaohu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708798/ https://www.ncbi.nlm.nih.gov/pubmed/31335695 http://dx.doi.org/10.1097/MD.0000000000016427

Ejemplares similares

Adjuvant Radiotherapy of Involved Field versus Elective Lymph Node in Patients with Operable Esophageal Squamous Cell Cancer: A Single Institution Prospective Randomized Controlled Study
por: Liu, Ruifeng, et al.
Publicado: (2021)

Review of possible mechanisms of radiotherapy resistance in cervical cancer
por: Zhang, Hanqun, et al.
Publicado: (2023)

Late-course accelerated Hyperfractionation vs. Conventional Fraction Radiotherapy under precise technology plus Concurrent Chemotherapy for Esophageal Squamous Cell Carcinoma: comparison of efficacy and side effects
por: Luo, Hongtao, et al.
Publicado: (2020)

A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours
por: Zhang, Hanqun, et al.
Publicado: (2022)

Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2023)

Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2022)

Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway
por: Luo, Hongtao, et al.
Publicado: (2020)

Stereotactic body radiation therapy or surgery for stage I–II non-small cell lung cancer treatment?—outcomes of a meta-analysis
por: Zhang, Qiuning, et al.
Publicado: (2019)

The efficacy and safety of chemo‐free therapy in epidermal growth factor receptor tyrosine kinase inhibitor‐resistant advanced non‐small cell lung cancer: A single‐arm, phase II study
por: Zhang, Shuyang, et al.
Publicado: (2023)

Efficacy and safety of carbon‐ion radiotherapy for the malignant melanoma: A systematic review
por: Li, Chengcheng, et al.
Publicado: (2020)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer
por: Zhang, Qiuning, et al.
Publicado: (2019)

Safety and Efficacy of PD‐1/PD‐L1 inhibitors combined with radiotherapy in patients with non‐small‐cell lung cancer: a systematic review and meta‐analysis
por: Geng, Yichao, et al.
Publicado: (2021)

EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis
por: Du, Tian-Qi, et al.
Publicado: (2022)

Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report
por: Liu, Ruifeng, et al.
Publicado: (2022)

Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis
por: Li, Zheng, et al.
Publicado: (2021)

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)

Does particle radiation have superior radiobiological advantages for prostate cancer cells? A systematic review of in vitro studies
por: Du, Tian-Qi, et al.
Publicado: (2022)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
por: Park, Hyung Kyu, et al.
Publicado: (2017)

Charged Particle Irradiation for Pancreatic Cancer: A Systematic Review of In Vitro Studies
por: Wang, Dandan, et al.
Publicado: (2022)

Effect of Carbon Ion Radiation Induces Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis
por: Yang, Zhen, et al.
Publicado: (2021)

Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis
por: Yang, Zhen, et al.
Publicado: (2021)

Charged particle therapy for high-grade gliomas in adults: a systematic review
por: Wang, Yuhang, et al.
Publicado: (2023)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
por: Morin-Ben Abdallah, Sami, et al.
Publicado: (2017)

Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors
por: He, Liru, et al.
Publicado: (2020)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Preliminary study on radiosensitivity to carbon ions in human breast cancer
por: Zhang, Qiuning, et al.
Publicado: (2020)

Visualized Analysis of Heavy Ion Radiotherapy: Development, Barriers and Future Directions
por: Jin, Yuanchang, et al.
Publicado: (2021)

Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
por: Lin, Wei-Cheng, et al.
Publicado: (2019)

Evaluation of tyrosine kinase inhibitors combined with antiprogrammed cell death protein 1 antibody in tyrosine kinase inhibitor-responsive patients with microsatellite stable/proficient mismatch repair metastatic colorectal adenocarcinoma: protocol for open-label, single-arm trial
por: Dong, Qian, et al.
Publicado: (2022)

Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase
Publicado: (1995)

Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013)

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance
por: Heydt, Carina, et al.
Publicado: (2018)

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab
por: Chikaishi, Yasuhiro, et al.
Publicado: (2020)

Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)
por: Zhu, Qianqian, et al.
Publicado: (2017)

Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma
por: Qiao, Xiaojuan, et al.
Publicado: (2015)

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
por: Zhang, Haijun
Publicado: (2016)

Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2023)

LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway
por: Luo, Hongtao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rcpfglbgcif4eq81uj1acb1one